KFGO |
FDA approves new treatment for adults with mantle cell lymphoma
FDA.gov The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive ... FDA approves AstraZeneca's Calquence for rare blood cancer AstraZeneca wins US approval for lymphoma drug FDA Approves Calquence for Mantle Cell Lymphoma |
from Health - Google News http://ift.tt/2z7D376